OTC Cough, Cold & Allergy Medicine Market : Pharmacies will Continue to be the Top OCT Channel for Sales of Allergy

Posted on 2019-05-03 by Mark Hub in Healthcare // 0 Comments

Rockville, USA, 2019-May-03 — /EPR Network/ —There has been a notable transformation in the OTC cough, cold, and allergy medicines market, on the back of growing consciousness among medicine manufacturers to elevate the standards of their products, which in turn has positively influenced the market. Surging demands for effective drugs to cure inflammation among consumers is propelling the growth of the OTC cough, cold, and allergy medicine market at the global level.

Rising number of medicated consumers in concurrence to the increasing geriatric population at the global level is expected to remain a strong growth driver for this market. Additionally, demand from the consumers for these medicines is burgeoning rapidly, owing to the convenience of dosage in their fast-track life.

Request Sample here:

https://www.factmr.com/connectus/sample?flag=S&rep_id=71

Asia Pacific excluding Japan (APEJ) is projected to enjoy supremacy over the global OTC cough, cold, and allergy medicine market, attributed to the pervasiveness of air pollution in the geography and the reception rate of these inexpensive and effective medicines is on a higher side. Pharmacies, being the most accessible channel for these medicines, is forecasted to lead among its counterpart distribution channels, reports Fact.MR. Aforementioned demand drivers have been evaluated and the market is predicted to register a remarkable CAGR of about 4.9% through 2022.

OTC Cough, Cold, and Allergy Medicine Market: Crux of the Report

The major aim of this comprehensive report is to assess the OTC cough, cold, & allergy medicines market at the global level for the duration 2017 to 2022. The study will help the suppliers, stakeholders, and manufacturers of this market gain accurate analysis of the market. A detailed executive summary has been incorporated in the report, which draws the attention of the stakeholders towards statistics and important facts on the market.

Browse Full Report on OTC Cough, Cold, and Allergy Medicine Market with TOC

https://www.factmr.com/report/71/otc-cough-cold-allergy-medicine-market

The study extends its focus on the market drivers, opportunities, restraints, key trends, and recent developments in the market during the forecasted period. The study comprises of various macroeconomic and microeconomic factors and demand & supply trend analysis to offer a thorough understanding of this market. Market segmentation has been done on the basis of OTC channel, drug type, region, and dosage, which has been analyzed in the report. The report has been curated by culling important information from the primary and secondary sources.

For More Information Raise Enquiry

https://www.factmr.com/connectus/sample?flag=AE&rep_id=71

OTC Cough, Cold, and Allergy Medicine Market: Regional Segmentation and Competitive Dynamics

The market has been divided into Latin America, Europe, North America, Japan, Asia Pacific excluding Japan (APEJ), and Middle East and Africa (MEA). The region-based classification is detailed in nature and offers a country-specific forecast on various parameters.

The leading players in the market comprises of Johnson & Johnson Service, Inc., AstraZaneca Plc., Sanofi-Aventis, Sun Pharmaceutical Industries Ltd., Reckitt Benckiser Group Plc., GlaxoSmithKline Plc., Novartis AG, Prestige Brands Holdings, Inc., Bristol-Myers Squib Co., Procter & Gamble Co., Pfizer Inc., Allergen, and Merck & Co. A comprehensive information on pricing analysis, product sourcing, and cost structure has been incorporated in the report for each of these leading players, which will help the manufacturers and suppliers of the industry devise sustainable business strategies.

About Fact.MR

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

Matched content

Editor’s pick